hFCRN(2)

品系全名

C57BL/6Smoc-Fcgrtem2(hFCGRT)Smoc

目錄號

NM-HU-190070

品系狀態(tài)

活體

導(dǎo)出PDF

基因信息

基因名
Fcgrt

品系描述

通過同源重組,將小鼠基因Fcgrt(FcRn)進行人源化修飾。與此相似的品系還有hFCRN(NM-HU-00109)、hFCRN(NM-HU-2000032),詳細信息請咨詢技術(shù)顧問。
應(yīng)用領(lǐng)域:免疫治療;腫瘤研究;藥物篩選

驗證數(shù)據(jù)

Fcgrt.png

Fig1. Validation of hFCGRT and mFCGRT expression in humanized Fcgrt mice by Western blot. These results showed that hFCGRT can be expressed in the liver and kidney of humanized Fcgrt homozygous and heterozygous mice,while mFCGRT can not be expressed in the humanized Fcgrt homozygous mice.

image.png

Fig2. Blood concentration curves of Keytruda in C57BL/6 and hFcRn KI mice. (n=3/time point/group)

image.png

Fig3. Blood concentration curves of Cyramza(A) and Keytruda(B) in C57BL/6, hFcRn KI and Fcgrt-KO mice.(n=3/time point/group)

image.png

Fig4. In vivo PK profiles of TAA scfv-anti HSA VHH in hALB/hFCRN mice(NM-HU-200278) (female, 10-12weeks, n=3 mice/timepoint), which were generated by crossing hFCRN(NM-HU-190070) with hALB(NM-HU-200003). (In cooperation with the third party).

image.png

Fig5. Blood concentration curves of test articles in C57BL/6 and hFcRn/hALB dKI mice(NM-HU-200278) , which were generated by crossing hFCRN(NM-HU-190070) with hALB(NM-HU-200003).(In cooperation with the third party)



你也可能感興趣

Tamoxifen誘導(dǎo)Cre-ERT2小鼠 使用指南

Cre-ERT2在無Tamoxifen誘導(dǎo)的情況下,在細胞質(zhì)內(nèi)處于無活性狀態(tài);當(dāng)Tamoxifen誘導(dǎo)后,Tamoxifen的代謝產(chǎn)物4-OHT(雌激素類似物)與ERT結(jié)合,可使Cre-ERT2進核發(fā)揮Cre重組酶活性。

查看
【小鼠大學(xué)問】基因工程小鼠的命名規(guī)則

常見的基因工程小鼠可以分為兩種命名方式,包括基因定點修飾的小鼠命名,比如:敲除、敲入、點突變等等,和隨機轉(zhuǎn)基因的小鼠命名。

查看